EnhancedBio Inc.
4Patents
4Active
4Granted
50Portfolio score
Filing activity: Jun 26, 2017 → Aug 1, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10221418B2 | Composition for treating cancer associated with HPV infection | Chemistry; Metallurgy | 0 | Active |
| US11674184B2 | Enhancing radiation sensitivity comprising administering PMVK inhibiting siRNA and shRNA | Physics | 0 | Active |
| US11464870B2 | Lipid nanoparticles for in-vivo drug delivery, and uses thereof | Human Necessities | 0 | Active |
| US11911485B2 | Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.